| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| Company: GOG Partners |
| Recipient: You |
| Company: NRG Ovarian Committee Chair |
| Recipient: Your Institution |
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| Company: IDEOlogy Health |
| Recipient: You |
| Company: Medscape |
| Recipient: You |
| Company: Great Debates and Updates |
| Recipient: You |
| Company: OncLive/MJH Life Sciences |
| Recipient: You |
| Company: MD Outlook |
| Recipient: You |
| Company: Curio Science |
| Recipient: You |
| Company: Plexus |
| Recipient: You |
| Company: Congress Chanel |
| Recipient: You |
| Company: BIOPHARM |
| Recipient: You |
| Company: CEA/CCO |
| Recipient: You |
| Company: physician education resource (PER) |
| Recipient: You |
| Company: Research to Practice |
| Recipient: You |
| Company: Med Learning Group |
| Recipient: You |
| Company: Peerview |
| Recipient: You |
| Company: PeerVoice |
| Recipient: You |
| Company: CME Outfitters |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: Genentech/Roche |
| Recipient: You |
| Company: Immunogen |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: Merck |
| Recipient: You |
| Company: Verastem/Pharmacyclics |
| Recipient: You |
| Company: AADi |
| Recipient: You |
| Company: Iovance Biotherapeutics |
| Recipient: You |
| Company: Janssen Oncology |
| Recipient: You |
| Company: Regeneron |
| Recipient: You |
| Company: zentalis |
| Recipient: You |
| Company: Daiichi Sankyo Europe GmbH |
| Recipient: You |
| Company: BioNTech SE |
| Recipient: You |
| Company: immunocore |
| Recipient: You |
| Company: Takeda Science Foundation |
| Recipient: You |
| Company: zymeworks |
| Recipient: You |
| Company: Corcept Therapeutics |
| Recipient: You |
| Company: Loxo/Lilly |
| Recipient: You |
| Company: Abbvie |
| Recipient: You |
| Company: Tubulis GmbH |
| Recipient: You |
| Company: Kivu |
| Recipient: You |
| Company: Genmab/Seagen |
| Recipient: You |
| Company: Whitehawk |
| Recipient: You |
| Company: OnCusp Therapeutics |
| Recipient: You |
| Company: natera |
| Recipient: You |
| Company: BeiGene |
| Recipient: You |
| Company: Karyopharm Therapeutics |
| Recipient: You |
| Company: Day One Biopharmaceuticals |
| Recipient: You |
| Company: Debiopharm Group |
| Recipient: You |
| Company: Foundation Medicine |
| Recipient: You |
| Company: Gilead Sciences |
| Recipient: You |
| Company: PMV Pharma |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
| Company: Incyte |
| Recipient: You |
| Company: GSK/Tesaro |
| Recipient: Your Institution |
| Company: Duality Biologics |
| Recipient: Your Institution |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Merck |
| Recipient: Your Institution |
| Company: Regeneron |
| Recipient: Your Institution |
| Company: Verastem |
| Recipient: Your Institution |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Immunogen |
| Recipient: Your Institution |
| Company: Daiichi Sankyo/Lilly |
| Recipient: Your Institution |
| Company: Immunocore |
| Recipient: Your Institution |
| Company: Torl Biotherapeutics |
| Recipient: Your Institution |
| Company: Allarity Therapeutics |
| Recipient: Your Institution |
| Company: IDEAYA Biosciences |
| Recipient: Your Institution |
| Company: Zymeworks |
| Recipient: Your Institution |
| Company: Schrodinger |
| Recipient: Your Institution |
| Company: Whitehawk |
| Recipient: Your Institution |
| Company: Accent Therapeutics |
| Recipient: Your Institution |
| Company: teneoseven |
| Recipient: Your Institution |
| Company: Context Therapeutics |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| Please describe: I receive an annual royalty check for work done on "Up to Date" |
| Recipient: You |
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| Company: Abbvie |
| Recipient: You |
| Company: Daiichi Sankyo/Astra Zeneca |
| Recipient: You |
| Company: Takeda |
| Recipient: You |
| Company: Genmab |
| Recipient: You |
|
| Other Relationship |
| Company: GOG Partners |
| Recipient: Your Institution |
|
| (OPTIONAL) Uncompensated Relationships |
| Company: International Gynecologic Cancer Society |
| Recipient: You |
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|